https://ir.opusgtx.com/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/ocuphire/files/theme/images/logo-sm.png Equisolve Investor Relations Suite https://ir.opusgtx.com/press-releases/detail/538/opus-genetics-provides-best1-program-update-with-detailed-timeline-for-opgx-best1-results Thu, 09 Jul 26 07:00:00 -0400 https://ir.opusgtx.com/press-releases/detail/538/opus-genetics-provides-best1-program-update-with-detailed-timeline-for-opgx-best1-results https://ir.opusgtx.com/press-releases/detail/537/opus-genetics-announces-fda-alignment-on-phase-3-registrational-trial-design-for-opgx-lca5-in-lca5-associated-inherited-retinal-disease Mon, 06 Jul 26 07:00:00 -0400 https://ir.opusgtx.com/press-releases/detail/537/opus-genetics-announces-fda-alignment-on-phase-3-registrational-trial-design-for-opgx-lca5-in-lca5-associated-inherited-retinal-disease https://ir.opusgtx.com/press-releases/detail/536/opus-genetics-added-to-the-russell-3000-russell-2000-and-russell-microcap-indexes Fri, 26 Jun 26 09:15:00 -0400 https://ir.opusgtx.com/press-releases/detail/536/opus-genetics-added-to-the-russell-3000-russell-2000-and-russell-microcap-indexes https://ir.opusgtx.com/press-releases/detail/535/opus-genetics-highlights-five-gene-therapy-programs-targeting-significant-unmet-need-in-patients-with-inherited-retinal-diseases Tue, 16 Jun 26 16:05:00 -0400 https://ir.opusgtx.com/press-releases/detail/535/opus-genetics-highlights-five-gene-therapy-programs-targeting-significant-unmet-need-in-patients-with-inherited-retinal-diseases https://ir.opusgtx.com/press-releases/detail/534/opus-genetics-to-host-virtual-rd-science-forum-on-tuesday-june-16-2026-featuring-multiple-inherited-retinal-disease-experts Tue, 02 Jun 26 07:00:00 -0400 https://ir.opusgtx.com/press-releases/detail/534/opus-genetics-to-host-virtual-rd-science-forum-on-tuesday-june-16-2026-featuring-multiple-inherited-retinal-disease-experts https://ir.opusgtx.com/press-releases/detail/533/opus-genetics-reports-inducement-grants-under-nasdaq-listing-rule-5635c4 Thu, 28 May 26 16:01:00 -0400 https://ir.opusgtx.com/press-releases/detail/533/opus-genetics-reports-inducement-grants-under-nasdaq-listing-rule-5635c4 https://ir.opusgtx.com/press-releases/detail/532/opus-genetics-to-present-at-the-2026-jefferies-global-healthcare-conference Wed, 27 May 26 08:00:00 -0400 https://ir.opusgtx.com/press-releases/detail/532/opus-genetics-to-present-at-the-2026-jefferies-global-healthcare-conference https://ir.opusgtx.com/press-releases/detail/531/opus-genetics-to-present-at-the-rbc-capital-markets-2026-global-healthcare-conference Wed, 13 May 26 07:00:00 -0400 https://ir.opusgtx.com/press-releases/detail/531/opus-genetics-to-present-at-the-rbc-capital-markets-2026-global-healthcare-conference https://ir.opusgtx.com/press-releases/detail/530/opus-genetics-announces-financial-results-for-first-quarter-2026-and-provides-corporate-update Tue, 12 May 26 07:00:00 -0400 https://ir.opusgtx.com/press-releases/detail/530/opus-genetics-announces-financial-results-for-first-quarter-2026-and-provides-corporate-update https://ir.opusgtx.com/press-releases/detail/529/opus-genetics-presents-clinical-and-preclinical-data-at-arvo-2026-demonstrating-continued-pipeline-advancement-in-inherited-retinal-diseases Thu, 07 May 26 16:30:00 -0400 https://ir.opusgtx.com/press-releases/detail/529/opus-genetics-presents-clinical-and-preclinical-data-at-arvo-2026-demonstrating-continued-pipeline-advancement-in-inherited-retinal-diseases